Published in Biol Psychiatry on June 09, 2010
Robust changes in reward circuitry during reward loss in current and former cocaine users during performance of a monetary incentive delay task. Biol Psychiatry (2013) 0.97
Revise the revised? New dimensions of the neuroanatomical hypothesis of panic disorder. J Neural Transm (Vienna) (2012) 0.86
Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal. Neuropsychopharmacology (2013) 0.84
Neural substrates of defensive reactivity in two subtypes of specific phobia. Soc Cogn Affect Neurosci (2013) 0.82
Local synchronization of resting-state dynamics encodes Gray's trait Anxiety. PLoS One (2013) 0.79
Amygdala and Dorsal Anterior Cingulate Connectivity during an Emotional Working Memory Task in Borderline Personality Disorder Patients with Interpersonal Trauma History. Front Hum Neurosci (2014) 0.79
The role of the basolateral amygdala in punishment. Learn Mem (2015) 0.77
Regional inactivations of primate ventral prefrontal cortex reveal two distinct mechanisms underlying negative bias in decision making. Proc Natl Acad Sci U S A (2015) 0.77
The Behavioural Inhibition System, anxiety and hippocampal volume in a non-clinical population. Biol Mood Anxiety Disord (2014) 0.76
Persistent amygdala novelty response is associated with less anterior cingulum integrity in trauma-exposed women. Neuroimage Clin (2017) 0.75
Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med (2002) 20.68
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Long story short: the serotonin transporter in emotion regulation and social cognition. Nat Neurosci (2007) 3.66
Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2010) 3.13
Controlled aliasing in parallel imaging results in higher acceleration (CAIPIRINHA) for multi-slice imaging. Magn Reson Med (2005) 2.71
SMASH, SENSE, PILS, GRAPPA: how to choose the optimal method. Top Magn Reson Imaging (2004) 2.65
Dynamic autocalibrated parallel imaging using temporal GRAPPA (TGRAPPA). Magn Reson Med (2005) 2.62
Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. Am J Psychiatry (2012) 2.48
General formulation for quantitative G-factor calculation in GRAPPA reconstructions. Magn Reson Med (2009) 2.32
Targeting the murine serotonin transporter: insights into human neurobiology. Nat Rev Neurosci (2008) 2.21
Monitoring of monocyte recruitment in reperfused myocardial infarction with intramyocardial hemorrhage and microvascular obstruction by combined fluorine 19 and proton cardiac magnetic resonance imaging. Circulation (2013) 2.14
Controlled aliasing in volumetric parallel imaging (2D CAIPIRINHA). Magn Reson Med (2006) 2.08
Combined loss of Hey1 and HeyL causes congenital heart defects because of impaired epithelial to mesenchymal transition. Circ Res (2007) 2.05
Neural hyporesponsiveness and hyperresponsiveness during immediate and delayed reward processing in adult attention-deficit/hyperactivity disorder. Biol Psychiatry (2008) 2.04
Test-retest reliability of resting-state connectivity network characteristics using fMRI and graph theoretical measures. Neuroimage (2011) 2.03
Inversion recovery TrueFISP: quantification of T(1), T(2), and spin density. Magn Reson Med (2004) 1.98
Looking on the bright side of serotonin transporter gene variation. Biol Psychiatry (2010) 1.94
Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression. World J Biol Psychiatry (2007) 1.93
Serotonin transporter: gene, genetic disorders, and pharmacogenetics. Mol Interv (2004) 1.89
Case-control genome-wide association study of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2010) 1.86
Monoamine oxidase A gene promoter variation and rearing experience influences aggressive behavior in rhesus monkeys. Biol Psychiatry (2005) 1.81
Direct parallel image reconstructions for spiral trajectories using GRAPPA. Magn Reson Med (2006) 1.78
Field-of-view limitations in parallel imaging. Magn Reson Med (2004) 1.65
Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology (2003) 1.65
Source localization (LORETA) of the error-related-negativity (ERN/Ne) and positivity (Pe). Brain Res Cogn Brain Res (2004) 1.64
Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet (2011) 1.63
Ultrashort echo time imaging using pointwise encoding time reduction with radial acquisition (PETRA). Magn Reson Med (2011) 1.58
Nature and nurture predispose to violent behavior: serotonergic genes and adverse childhood environment. Neuropsychopharmacology (2007) 1.56
How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems. Neuropharmacology (2008) 1.56
The epigenome and postnatal environmental influences in psychotic disorders. Soc Psychiatry Psychiatr Epidemiol (2014) 1.51
Annual research review: The (epi)genetics of neurodevelopmental disorders in the era of whole-genome sequencing--unveiling the dark matter. J Child Psychol Psychiatry (2015) 1.48
2D-GRAPPA-operator for faster 3D parallel MRI. Magn Reson Med (2006) 1.48
Acceptance of medical training cases as supplement to lectures. GMS Z Med Ausbild (2011) 1.47
Accelerated volumetric MRI with a SENSE/GRAPPA combination. J Magn Reson Imaging (2006) 1.45
5-HTTLPR biases amygdala activity in response to masked facial expressions in major depression. Neuropsychopharmacology (2007) 1.44
The genome of the platyfish, Xiphophorus maculatus, provides insights into evolutionary adaptation and several complex traits. Nat Genet (2013) 1.42
Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology (2004) 1.41
Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology (2003) 1.36
Deficiency of brain 5-HT synthesis but serotonergic neuron formation in Tph2 knockout mice. J Neural Transm (Vienna) (2008) 1.36
Non-Cartesian data reconstruction using GRAPPA operator gridding (GROG). Magn Reson Med (2007) 1.33
Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD. Neuropsychopharmacology (2009) 1.33
Identifying molecular substrates in a mouse model of the serotonin transporter x environment risk factor for anxiety and depression. Biol Psychiatry (2007) 1.32
Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology (2008) 1.31
Differential functional variability of serotonin transporter and monoamine oxidase a genes in macaque species displaying contrasting levels of aggression-related behavior. Behav Genet (2005) 1.29
Serotonin-1A receptor gene HTR1A variation predicts interferon-induced depression in chronic hepatitis C. Gastroenterology (2007) 1.29
Neural response to reward anticipation is modulated by Gray's impulsivity. Neuroimage (2009) 1.27
Reconstruction of undersampled non-Cartesian data sets using pseudo-Cartesian GRAPPA in conjunction with GROG. Magn Reson Med (2008) 1.27
Integrating neurobiological markers of depression. Arch Gen Psychiatry (2010) 1.24
Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions. Behav Pharmacol (2008) 1.23
Spatio-temporal expression of tryptophan hydroxylase isoforms in murine and human brain: convergent data from Tph2 knockout mice. Eur Neuropsychopharmacol (2009) 1.22
IR TrueFISP with a golden-ratio-based radial readout: fast quantification of T1, T2, and proton density. Magn Reson Med (2012) 1.21
Simulation of near-infrared light absorption considering individual head and prefrontal cortex anatomy: implications for optical neuroimaging. PLoS One (2011) 1.21
Spatial distribution of RF-induced E-fields and implant heating in MRI. Magn Reson Med (2008) 1.20
Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter. Neuropharmacology (2005) 1.20
Reduced amygdala-prefrontal coupling in major depression: association with MAOA genotype and illness severity. Int J Neuropsychopharmacol (2008) 1.18
Measuring RF-induced currents inside implants: Impact of device configuration on MRI safety of cardiac pacemaker leads. Magn Reson Med (2009) 1.18
Toward a molecular architecture of personality. Behav Brain Res (2003) 1.18
Early-stage face processing dysfunction in patients with schizophrenia. Am J Psychiatry (2004) 1.16
Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption. Neuropsychopharmacology (2010) 1.16
Iron oxide labelling of human mesenchymal stem cells in collagen hydrogels for articular cartilage repair. Biomaterials (2007) 1.16
A brief review of parallel magnetic resonance imaging. Eur Radiol (2003) 1.15
Dopamine and cognitive control: the influence of spontaneous eyeblink rate and dopamine gene polymorphisms on perseveration and distractibility. Behav Neurosci (2005) 1.15
Association of the functional -1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder. Int J Neuropsychopharmacol (2005) 1.15
Additive effects of serotonin transporter and tryptophan hydroxylase-2 gene variation on emotional processing. Cereb Cortex (2006) 1.14
3,4-methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice. Biol Psychiatry (2007) 1.14
Parallel magnetic resonance imaging using the GRAPPA operator formalism. Magn Reson Med (2005) 1.14
Tryptophan hydroxylase-2 (TPH2) in disorders of cognitive control and emotion regulation: a perspective. Psychoneuroendocrinology (2011) 1.13
Association of the COMT val158met variant with antidepressant treatment response in major depression. Neuropsychopharmacology (2007) 1.13
Autocalibrated coil sensitivity estimation for parallel imaging. NMR Biomed (2006) 1.13
Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women. Int J Neuropsychopharmacol (2004) 1.12
Neurogenesis and schizophrenia: dividing neurons in a divided mind? Eur Arch Psychiatry Clin Neurosci (2007) 1.12
Rationale and design of a randomised, controlled, multicenter trial investigating the effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in depressed heart failure patients (MOOD-HF). Eur J Heart Fail (2007) 1.12
Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: genome-wide association study of both common and rare variants. Am J Med Genet B Neuropsychiatr Genet (2013) 1.11
Dynamic ¹³C/¹ H NMR imaging uncovers sugar allocation in the living seed. Plant Biotechnol J (2011) 1.10
High loading of polygenic risk for ADHD in children with comorbid aggression. Am J Psychiatry (2013) 1.10
Functional near-infrared spectroscopy: a long-term reliable tool for measuring brain activity during verbal fluency. Neuroimage (2008) 1.10